Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Therapeutic Advances in Psychopharmacology
|
August 25, 2015
Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use
Suzanne Law, Peter M Haddad, Imran B Chaudhry, et al.
Bjpsych Open
|
September 20, 2021
The COVID-19 pandemic: an opportunity to make mental health a higher public health priority
Javed Latoo, Peter M Haddad, Minal Mistry, et al.
Therapeutic Advances in Psychopharmacology
|
February 4, 2014
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects
Peter M Haddad, W Wolfgang Fleischhacker, Joseph Peuskens, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 11, 2025
Health service experiences of LGBTQA+ adults in Australia with psychotic disorders, common mental disorders and physical health conditions: Findings from the <i>Private Lives 3</i> national survey
Cláudia C Gonçalves, Ashleigh Lin, Adam O Hill, et al.
Schizophrenia Research
|
August 16, 2015
Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale
Caroline Hynes, Dolores Keating, Stephen McWilliams, et al.
International Journal of Bipolar Disorders
|
February 4, 2017
Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan
Muhammad Ishrat Husain, Imran B Chaudhry, Raza R Rahman, et al.
Neuropsychiatric Disease and Treatment
|
December 30, 2016
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
Muhammad I Husain, Imran B Chaudhry, Munir M Hamirani, et al.
BMC Psychiatry
|
March 12, 2021
Quality of diabetes care in patients with schizophrenia: a case-control study in Qatar
Mustafa Abdul Karim, Nadeen Al-Baz, Sami Ouanes, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 26, 2013
The size, burden and cost of disorders of the brain in the UK
Naomi A Fineberg, Peter M Haddad, Lewis Carpenter, et al.
Clinical Drug Investigation
|
January 5, 2013
Improving treatment adherence in your patients with schizophrenia: the STAY initiative
Fernando Cañas, Koksal Alptekin, Jean Michel Azorin, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Therapeutic Advances in Psychopharmacology
|
August 25, 2015
Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use
Suzanne Law, Peter M Haddad, Imran B Chaudhry, et al.
Bjpsych Open
|
September 20, 2021
The COVID-19 pandemic: an opportunity to make mental health a higher public health priority
Javed Latoo, Peter M Haddad, Minal Mistry, et al.
Therapeutic Advances in Psychopharmacology
|
February 4, 2014
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects
Peter M Haddad, W Wolfgang Fleischhacker, Joseph Peuskens, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 11, 2025
Health service experiences of LGBTQA+ adults in Australia with psychotic disorders, common mental disorders and physical health conditions: Findings from the <i>Private Lives 3</i> national survey
Cláudia C Gonçalves, Ashleigh Lin, Adam O Hill, et al.
Schizophrenia Research
|
August 16, 2015
Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale
Caroline Hynes, Dolores Keating, Stephen McWilliams, et al.
International Journal of Bipolar Disorders
|
February 4, 2017
Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan
Muhammad Ishrat Husain, Imran B Chaudhry, Raza R Rahman, et al.
Neuropsychiatric Disease and Treatment
|
December 30, 2016
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
Muhammad I Husain, Imran B Chaudhry, Munir M Hamirani, et al.
BMC Psychiatry
|
March 12, 2021
Quality of diabetes care in patients with schizophrenia: a case-control study in Qatar
Mustafa Abdul Karim, Nadeen Al-Baz, Sami Ouanes, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 26, 2013
The size, burden and cost of disorders of the brain in the UK
Naomi A Fineberg, Peter M Haddad, Lewis Carpenter, et al.
Clinical Drug Investigation
|
January 5, 2013
Improving treatment adherence in your patients with schizophrenia: the STAY initiative
Fernando Cañas, Koksal Alptekin, Jean Michel Azorin, et al.
Page
of 10